4/A//SEC Filing
Gupta Rishi 4/A
Accession 0001415889-24-004488
CIK 0001672619other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 7:30 PM ET
Size
5.9 KB
Accession
0001415889-24-004488
Insider Transaction Report
Form 4/AAmended
Gupta Rishi
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-02-13+23,364→ 23,364 totalExercise: $14.85Exp: 2034-02-13→ Common Stock (23,364 underlying)
Footnotes (2)
- [F1]The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant.
- [F2]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001537370
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 7:30 PM ET
- Size
- 5.9 KB